Cargando…
Beyond The T/C Ratio: Old And New Anticancer Activity Scores In Vivo
Assessing the efficacy of anticancer agents in animal models remains a necessary step in the development of new treatment options and plays an important role in their optimization and comparison. Often, however, interpretation of the results is flawed by excessive trust in scores traditionally hande...
Autor principal: | Ubezio, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756833/ https://www.ncbi.nlm.nih.gov/pubmed/31572007 http://dx.doi.org/10.2147/CMAR.S215729 |
Ejemplares similares
-
Improved analysis of bacterial CGH data beyond the log-ratio paradigm
por: Snipen, Lars, et al.
Publicado: (2009) -
Dynamic Rendering of the Heterogeneous Cell Response to Anticancer Treatments
por: Falcetta, Francesca, et al.
Publicado: (2013) -
Interactive Journal Club: Teaching an Old Dog New Tricks
por: Rosenthal, Judith, et al.
Publicado: (2017) -
Limitations of the incidence density ratio as approximation of the hazard ratio
por: Bender, Ralf, et al.
Publicado: (2019) -
A new approach to grant review assessments: score, then rank
por: Gallo, Stephen A., et al.
Publicado: (2023)